A Phage, a New Antibiotic and a Long Road Home: The Story of a 19-Year-Old Facing an Almost Untreatable Infection
By the time a bacteriophage was finally administered to her, a 19-year-old woman in California had already spent months fighting for her life. She had faced acute myeloid leukaemia, multiple organ failure, prolonged intensive care, and a rare condition that caused extensive and extremely painful skin wounds. Then another threat emerged: an infection caused by Pseudomonas aeruginosa , a bacterium resistant to almost every antibiotic available to her medical team. With conventional treatment options running out, doctors turned to an unusual combination of two experimental strategies: a virus capable of infecting bacteria and an antibiotic that had never before been administered clinically in the United States. Researcher Matthew Henry examining bacterial cultures infected with bacteriophage products at the Naval Medical Research Command. Phage susceptibility testing is an essential step in developing personalised bacteriophage treatments. U.S. Navy photo by Michael Wilson (2024). Her sto...